Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2Head & Neck 1Gastrointestinal 1

Conditions

Lung Neoplasms 2Sarcoidosis 1Lung Diseases, Interstitial 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Conscious Sedation × Thoracic × Clear all
NCT02245295 2016-11-15

The Role of Sedation Technique in EBUS-TBNA

University of Zurich

Completed
232 enrolled
Thoracic

Lung Neoplasms

NCT02246023 2016-04-14

Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy

University of Zurich

Phase 4 Completed
78 enrolled
Thoracic

Lung Neoplasms, Sarcoidosis, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡